Chemoinformaics analysis of 3-(4-Hydroxyphenyl)Propionic Acid
| Molecular Weight | 166.176 | nRot | 3 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 7 |
| Exact Molecular Weight | 166.063 | nRing | 1 |
| Solubility: LogS | -1.442 | nHRing | 0 |
| Solubility: LogP | 1.117 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.1039 |
| nHD | 2 | BPOL | 10.9001 |
| QED | 0.713 |
| Synth | 1.521 |
| Natural Product Likeliness | 0.602 |
| NR-PPAR-gamma | 0.397 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.02 |
| CACO-2 | -5.163 |
| MDCK | 0.0000108 |
| BBB | 0.093 |
| PPB | 0.680971 |
| VDSS | 0.213 |
| FU | 0.21675 |
| CYP1A2-inh | 0.047 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.548 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.073 |
| CL | 13.199 |
| T12 | 0.894 |
| hERG | 0.035 |
| Ames | 0.029 |
| ROA | 0.565 |
| SkinSen | 0.285 |
| Carcinogencity | 0.458 |
| EI | 0.972 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.888168 |